Testicular Cancer

Such therapeutic effects were more pronounced in combination than monotherapy. In conclusion, our study found that combining SIT and MAN had a remarkably beneficial impact on PTX-induced testicular toxicity by mediating the Sestrin2/Keap1/Nrf2 signaling pathway.

These findings demonstrate a distinct surface antigen landscape in testicular GCTs, with CLDN6, EGFR, and TROP2 emerging as leading candidates for further translational evaluation. Enrichment of these targets highlights antigenic heterogeneity within GCTs and supports further validation in appropriate disease settings including metastatic, post-treatment, and relapsed or refractory disease.

Testicular germ cell tumors (TGCTs) are the most common solid malignancies in young men and, despite high cure rates with cisplatin-based multimodal therapy, a clinically relevant subset of patients develops relapsed, platinum-refractory, or treatment-resistant disease with limited salvage options and substantial long-term morbidity...We argue that the next phase of the field should move beyond descriptive biomarker studies toward mechanism-based, TGCT-specific translational strategies integrating miRNA mimics, antagomirs, extracellular vesicles, or miRNA-augmented cellular therapies with immune-priming approaches such as epigenetic therapy, radiotherapy, vaccines, or CAR-T platforms. Such a framework could enable more precise biological stratification and improve the efficacy, durability, and tolerability of immunotherapy in refractory TGCT.

Additional variants in MSH6 and CTU2 were also identified and may act as potential modifiers of disease susceptibility, consistent with a multigenic contribution to TGCT risk. These findings support a contributory role for the PDE11A locus in TGCT predisposition and underscore the biological relevance of overlapping sense-antisense genomic regions in hereditary cancer studies.

These findings provide proof-of-concept that site-directed RNA editing can be used to reprogram tumor immunogenicity by generating defined neoantigen-like epitopes from shared tumor-associated antigens. This strategy may expand neoantigen-based immunotherapy beyond tumors with high mutational burden and warrants further investigation for clinical translation.

In 786-O and ACHN cells, chronic exposure to an environmentally relevant concentration of BaP significantly increased CASP9 protein stability without altering its mRNA expression, suggesting post-transcriptional regulation. Collectively, these findings identify shared molecular targets of EDCs across urogenital cancers and provide new mechanistic insight into EDC-driven tumor progression, prioritizing potential biomarkers and therapeutic targets for environmentally related malignancies.

P=N/A, N=142, Not yet recruiting, University of Michigan Rogel Cancer Center | Trial completion date: Aug 2029 --> Aug 2027 | Trial primary completion date: Aug 2029 --> Aug 2027

Immunohistochemical analysis showed diffuse positivity for cluster of differentiation 34 (CD34). These findings supported the diagnosis of paratesticular SFT.

Histology showed benign spindle cells, low Ki-67 (~3%), and positivity for desmin and CD34. This case emphasizes recognition and testis-sparing management of paratesticular leiomyoma, ensuring excellent outcomes without need for long-term surveillance.

These findings raise suspicion for Lynch syndrome. This case is interesting because seminoma and colorectal cancer were both identified in a patient with features suggestive of a hereditary cancer syndrome.

miR-371a-3p and cfDNA provide independent information in TGCT, miR-371a-3p being associated with the active disease presence, while total cfDNA levels are increased during the active treatment, reflecting different biology and dynamics of the two circulating biomarkers. These findings have implications for future studies on disease monitoring in TGCT. The sensitivity of miR-371a-3p detection in this real practice cohort is lower than reported previously, suggesting assay standardization and clinical studies setting are warranted before miR-371a-3p implementation into clinical practice.

This case underscores the importance of considering germ cell tumors in the differential diagnosis of hemorrhagic brain lesions, particularly in young males. Early surgical intervention, combined with systemic chemotherapy, can lead to favorable neurological and oncologic outcomes even in such rare and aggressive presentations.